Literature DB >> 33717688

Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly.

Diego Añazco1, Bryan Nicolalde1, Isabel Espinosa1, Jose Camacho2, Mariam Mushtaq1, Jimena Gimenez1, Enrique Teran1.   

Abstract

BACKGROUND: Preprints are preliminary reports that have not been peer-reviewed. In December 2019, a novel coronavirus appeared in China, and since then, scientific production, including preprints, has drastically increased. In this study, we intend to evaluate how often preprints about COVID-19 were published in scholarly journals and cited.
METHODS: We searched the iSearch COVID-19 portfolio to identify all preprints related to COVID-19 posted on bioRxiv, medRxiv, and Research Square from January 1, 2020, to May 31, 2020. We used a custom-designed program to obtain metadata using the Crossref public API. After that, we determined the publication rate and made comparisons based on citation counts using non-parametric methods. Also, we compared the publication rate, citation counts, and time interval from posting on a preprint server to publication in a scholarly journal among the three different preprint servers.
RESULTS: Our sample included 5,061 preprints, out of which 288 were published in scholarly journals and 4,773 remained unpublished (publication rate of 5.7%). We found that articles published in scholarly journals had a significantly higher total citation count than unpublished preprints within our sample (p < 0.001), and that preprints that were eventually published had a higher citation count as preprints when compared to unpublished preprints (p < 0.001). As well, we found that published preprints had a significantly higher citation count after publication in a scholarly journal compared to as a preprint (p < 0.001). Our results also show that medRxiv had the highest publication rate, while bioRxiv had the highest citation count and shortest time interval from posting on a preprint server to publication in a scholarly journal.
CONCLUSIONS: We found a remarkably low publication rate for preprints within our sample, despite accelerated time to publication by multiple scholarly journals. These findings could be partially attributed to the unprecedented surge in scientific production observed during the COVID-19 pandemic, which might saturate reviewing and editing processes in scholarly journals. However, our findings show that preprints had a significantly lower scientific impact, which might suggest that some preprints have lower quality and will not be able to endure peer-reviewing processes to be published in a peer-reviewed journal.
© 2021 Añazco et al.

Entities:  

Keywords:  COVID-19; Crossref; Preprints; Preprints servers; iSearch COVID-19 portfolio

Year:  2021        PMID: 33717688      PMCID: PMC7936563          DOI: 10.7717/peerj.10927

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  15 in total

1.  New preprint server for medical research.

Authors:  Claire Rawlinson; Theodora Bloom
Journal:  BMJ       Date:  2019-06-05

2.  The coronavirus pandemic in five powerful charts.

Authors:  Ewen Callaway; David Cyranoski; Smriti Mallapaty; Emma Stoye; Jeff Tollefson
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

3.  The preprint dilemma.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2017-09-28       Impact factor: 47.728

4.  How swamped preprint servers are blocking bad coronavirus research.

Authors:  Diana Kwon
Journal:  Nature       Date:  2020-05       Impact factor: 49.962

5.  Medical Journals and the 2019-nCoV Outbreak.

Authors:  Eric J Rubin; Lindsey R Baden; Stephen Morrissey; Edward W Campion
Journal:  N Engl J Med       Date:  2020-01-27       Impact factor: 91.245

6.  Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.

Authors:  Mahir Fidahic; Danijela Nujic; Renata Runjic; Marta Civljak; Filipa Markotic; Zvjezdana Lovric Makaric; Livia Puljak
Journal:  BMC Med Res Methodol       Date:  2020-06-22       Impact factor: 4.615

7.  Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.

Authors:  Mandeep R Mehra; Sapan S Desai; SreyRam Kuy; Timothy D Henry; Amit N Patel
Journal:  N Engl J Med       Date:  2020-06-04       Impact factor: 91.245

8.  Data sharing for novel coronavirus (COVID-19).

Authors:  Vasee Moorthy; Ana Maria Henao Restrepo; Marie-Pierre Preziosi; Soumya Swaminathan
Journal:  Bull World Health Organ       Date:  2020-03-01       Impact factor: 9.408

9.  Preprints: An underutilized mechanism to accelerate outbreak science.

Authors:  Michael A Johansson; Nicholas G Reich; Lauren Ancel Meyers; Marc Lipsitch
Journal:  PLoS Med       Date:  2018-04-03       Impact factor: 11.069

10.  COVID-19 research: pandemic versus "paperdemic", integrity, values and risks of the "speed science".

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Forensic Sci Res       Date:  2020-06-10
View more
  12 in total

1.  Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis.

Authors:  Jeremy Otridge; Cynthia L Ogden; Kyle T Bernstein; Martha Knuth; Julie Fishman; John T Brooks
Journal:  JMIR Public Health Surveill       Date:  2022-07-15

2.  Preprint citation practice in PLOS.

Authors:  Marc Bertin; Iana Atanassova
Journal:  Scientometrics       Date:  2022-05-25       Impact factor: 3.801

3.  Scientific literacy and preferred resources used by Latin American medical students during the COVID-19 pandemic: A multinational survey.

Authors:  Bryan Nicolalde; Diego Añazco; Maria Jose Jaramillo-Cartwright; Ivonne Salinas; Aldo Pacheco-Carrillo; Saliha Hernández-Chávez; Gimena Moyano; Enrique Teran
Journal:  F1000Res       Date:  2022-03-21

Review 4.  A Review of the Scientific Contributions of Nepal on COVID-19.

Authors:  Rupesh Raut; Ranjit Sah; Kritika Dixit; Alfonso J Rodriguez-Morales; Zenteno Marco; Kuldeep Dhama; Yashpal Singh Malik; Ruchi Tiwari; D Katterine Bonilla-Aldana; Angel Lee
Journal:  Curr Trop Med Rep       Date:  2021-11-01

5.  Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study.

Authors:  Maia Salholz-Hillel; Peter Grabitz; Nicholas J DeVito; Molly Pugh-Jones; Daniel Strech
Journal:  BMJ Open       Date:  2021-11-22       Impact factor: 2.692

6.  Recalibrating the notion of modelling for policymaking during pandemics.

Authors:  Yot Teerawattananon; Sarin Kc; Y-Ling Chi; Saudamini Dabak; Joseph Kazibwe; Hannah Clapham; Claudia Lopez Hernandez; Gabriel M Leung; Hamid Sharifi; Mahlet Habtemariam; Mark Blecher; Sania Nishtar; Swarup Sarkar; David Wilson; Kalipso Chalkidou; Marelize Gorgens; Raymond Hutubessy; Suwit Wibulpolprasert
Journal:  Epidemics       Date:  2022-03-02       Impact factor: 4.396

7.  Reproducibility of Research During COVID-19: Examining the Case of Population Density and the Basic Reproductive Rate from the Perspective of Spatial Analysis.

Authors:  Antonio Paez
Journal:  Geogr Anal       Date:  2021-11-18

Review 8.  Publish or perish, information overload, and journal impact factors - A conflicting tripod of forces.

Authors:  Victor Grech
Journal:  Saudi J Anaesth       Date:  2022-03-17

9.  Comparison of citation rates between Covid-19 and non-Covid-19 articles across 24 major scientific journals.

Authors:  Michael D Brandt; Sherief A Ghozy; David F Kallmes; Robert J McDonald; Ramanathan D Kadirvel
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

10.  Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.

Authors:  Jean-Francois Gehanno; Julien Grosjean; Stefan J Darmoni; Laetitia Rollin
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.